Financial Performance - AMN Healthcare reported quarterly revenue of $658 million, an 11% decrease year-over-year and a 5% decrease sequentially [5][8] - The company experienced a net loss of $116.2 million, translating to a diluted loss per share of ($3.02) [5][13] - Adjusted diluted EPS was $0.30, down 69% from the same quarter last year [5][13] Segment Performance - Revenue from the Nurse and Allied Solutions segment was $382 million, a 14% decline year-over-year and an 8% decline from the previous quarter [6][38] - The Physician and Leadership Solutions segment reported revenue of $175 million, down 6% year-over-year and flat sequentially [7][38] - Technology and Workforce Solutions segment revenue was $102 million, a decrease of 9% year-over-year and flat sequentially [10][38] Operational Highlights - The company achieved a consolidated gross margin of 29.8%, which is 120 basis points lower year-over-year but improved by 110 basis points sequentially [11][38] - SG&A expenses were $155 million, representing 23.5% of revenue, an increase from 20.1% in the same quarter last year [12][38] - Cash flow from operations was strong at $79 million, allowing the company to reduce debt by $80 million, resulting in a net leverage ratio of 3.3:1 [8][14] Future Outlook - For Q3 2025, consolidated revenue is expected to be 9-11% lower than the prior year, with specific segment declines projected [17][18] - The company anticipates a gross margin between 28.7% and 29.2% for the upcoming quarter [17] - Labor disruption revenue assumed in guidance is $5 million [18] Strategic Developments - The sale of Smart Square for $75 million is part of the company's strategy to enhance its partnership with symplr [15][16] - AMN Passport, the company's app for healthcare professionals, surpassed 300,000 users, indicating growth in its technology-enabled services [8]

Core Insights - The average starting salary for physicians is $403,000, with orthopedic surgeons earning the highest at $576,000 and pediatricians the lowest at $258,000 [1][2][3] Salary Trends - Specialists, particularly orthopedic surgeons, gastroenterologists ($552,000), urologists ($521,000), radiologists ($500,000), and hematologists/oncologists ($490,000), command the highest starting salaries [2][3] - The average starting salary for otolaryngologists increased by 36% from $358,000 to $487,000, while cardiologists saw a 19% increase from $396,000 to $470,000, and hematologists/oncologists increased by 10% from $444,000 to $490,000 [4] Demand for Healthcare Professionals - There is a strong demand for specialists driven by the growing senior citizen population, leading to high starting salary offers [3] - The five specialties with the most demand are hematologists/oncologists, gastroenterologists, endocrinologists, and radiologists, although job prospects are abundant across all medical specialties [5][6] Nurse Practitioners (NPs) Salary Insights - The average starting salary for NPs is $180,000, reflecting a 9.6% increase from $164,000 in 2024 [5] Additional Compensation - Physicians are offered an average signing bonus of $38,315 (up 23% from $31,103), a relocation allowance of $12,619 (up 12% from $11,284), and a continuing medical education allowance of $4,073 (up 3% from $3,969) [6][7] - The combined average of signing bonuses, relocation, and CME allowances totals $58,854, in addition to the average starting salary of $403,000 [7] Report Overview - The data is based on a representative sample of 1,420 search engagements conducted by AMN Healthcare from April 1, 2024, to March 31, 2025 [8]

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Cross Country Healthcare (CCRN) due to lower revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The upcoming earnings report is expected to show quarterly earnings of $0.07 per share, reflecting a 30% decrease year-over-year, and revenues of $293.95 million, down 13.5% from the previous year [3]. - The consensus EPS estimate has been revised down by 2.27% over the last 30 days, indicating a bearish sentiment among analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Cross Country is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -44.44%, suggesting a challenging outlook for beating earnings expectations [12]. - The stock currently holds a Zacks Rank of 4, further complicating the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Cross Country was expected to post earnings of $0.04 per share but exceeded expectations with earnings of $0.06, resulting in a surprise of +50.00% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates twice [14]. Conclusion - Cross Country does not appear to be a strong candidate for an earnings beat, and investors should consider additional factors when evaluating the stock ahead of the earnings release [17].

Group 1 - AMN Healthcare Services, Inc. has scheduled a conference call for August 7, 2025, to discuss its Q2 2025 financial results and Q3 2025 outlook [1] - The earnings news release is expected to be issued after market close on the same day at approximately 4:15 p.m. Eastern Time [1] - A live webcast of the call will be accessible through a provided link and on AMN Healthcare's investor relations website [2] Group 2 - Following the call, a replay of the webcast will be available on the Company's investor relations website [3] - AMN Healthcare is recognized as a leader in total talent solutions for healthcare, addressing workforce challenges to improve clinical outcomes [4] - In 2024, AMN Healthcare professionals reached nearly 15 million patients across over 2,100 healthcare systems, including 87% of the top healthcare systems nationwide [4] Group 3 - The Company's common stock is listed under the symbol "AMN" on the New York Stock Exchange [5] - AMN Healthcare provides various channels for distributing information, including email alerts and RSS feeds [5] - Contact information for investor relations is available, including a dedicated Vice President for Investor Relations and Strategy [6]

Company Overview - AMN Healthcare is a leader and innovator in total talent solutions for healthcare, uniquely positioned to serve growing health systems and diverse care settings[5] - The company has over 12,000 total employees[8] - AMN Healthcare has a strong ESG/CSR track record[8] Financial Performance - In 2019, AMN Healthcare's revenue was $2.222 billion, with a gross profit of $743 million and a gross margin of 33.5%[8] - Adjusted EBITDA for 2019 was $277 million, representing an adjusted EBITDA margin of 12.5%[8] - Free cash flow in 2019 was $190 million, with a free cash flow conversion rate of 68%[8] - As of Q3 2020, Nurse and Allied Solutions accounted for 69% of revenue, Physician and Leadership Solutions 20%, and Technology and Workforce Solutions 11%[8, 11] - Managed Services Programs (MSPs) account for 56% of revenue from these segments[12] Market Position and Strategy - AMN Healthcare manages over $3.4 billion in spend under management[19] - The company is well-positioned to capture long-term U.S secular trends, including the aging population and healthcare professionals, job openings/turnover, and healthcare spend[37] - The total addressable market is approximately $22 billion, including $17 billion for the U.S Healthcare Staffing Market and $5 billion for other addressable markets[42, 43] - The company's strategic approach to M&A focuses on accretive profit margins and revenue growth, with a ROIC greater than the cost of capital[104]

Core Insights - The article discusses the potential for AMN Healthcare Services, Inc. to experience accelerated free cash flow growth due to shifts in US age demographics and the implementation of its WorkWise and ShiftWise solutions [1]. Company Overview - AMN Healthcare Services, Inc. is positioned to benefit from demographic changes in the US, which may lead to increased demand for its services [1]. Investment Strategy - The author emphasizes a focus on small and medium-cap companies, particularly in mature industries such as mining, oil and gas, and real estate, indicating a preference for deep value investments and dividend investing [1]. Financial Expectations - The author targets an internal rate of return of approximately 5%-7% for investments, reflecting a conservative investment approach [1].

Financial Performance & Growth - The company's LTM (Last Twelve Months) revenue as of September 30, 2022, was approximately $5.5 billion[13] - The company's LTM Adjusted EBITDA reached $895 million[82] - The company's LTM Free Cash Flow reached $550 million[87] - The company's revenue increased from $1.988 billion in FY17 to $5.481 billion LTM[82] - The company's Adjusted EBITDA margin was 16.3% LTM[82] Market Position & Strategy - The company estimates a total addressable market of approximately $46 billion[53] - The company estimates the 2022 U.S Healthcare Staffing Market is approximately $40 billion[54] - The company's revenue from Technology and Workforce Solutions was 12% of total revenue in Q3 2022[61] - The company spent $378 million with small businesses and diverse-owned companies[44] Capital Allocation & Debt - The company's total debt was $850 million as of September 30, 2022[92] - The company has $534 million in total available liquidity as of September 30, 2022[92]

Core Viewpoint - AMN Healthcare Services (AMN) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Ratings - The Zacks rating system is based on changes in earnings estimates, which are tracked through the Zacks Consensus Estimate for EPS from sell-side analysts [2]. - The Zacks rating upgrade for AMN reflects an optimistic earnings outlook, likely leading to increased buying pressure and a rise in stock price [4][6]. Impact of Institutional Investors - Changes in a company's future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with stock price movements, largely due to institutional investors adjusting their valuations based on these estimates [5]. - An increase in earnings estimates typically results in higher fair value for a stock, prompting institutional investors to buy or sell accordingly, which influences stock price movements [5]. Earnings Estimate Revisions for AMN - For the fiscal year ending December 2025, AMN is expected to earn $1.08 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 9.7% over the past three months [9]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, where Zacks Rank 1 stocks have generated an average annual return of +25% since 1988 [8]. - AMN's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [11].

Core Insights - AMN Healthcare has elected Celia Huber to its Board of Directors, bringing over 30 years of experience in healthcare strategy and governance [1][3] - Huber's expertise includes advising healthcare systems and payors on strategy, risk, and performance, aligning with AMN's mission to enhance workforce solutions [2][3] Company Overview - AMN Healthcare is recognized as a leader in total talent solutions for healthcare organizations in the U.S., focusing on solving workforce challenges to improve clinical outcomes [7] - The company offers a comprehensive network of healthcare professionals and a customizable suite of workforce technologies [7] Leadership Background - Celia Huber is a Senior Partner at McKinsey & Company, leading the Board Services Practice in North America, and has extensive experience in governance and organizational transformation [3][5] - Huber has served on various boards and committees, including the AltaMed Foundation and the California Business Roundtable, showcasing her commitment to healthcare and community service [5]

Company Overview and Strategy - Cross Country Healthcare aims to be a digitally transformed, innovative enterprise addressing clients' labor challenges[5] - The company's mission is connecting people and jobs through technology and solutions, prioritizing clinical excellence and patient care[6] - A key strategy involves expanding market presence with the Intellify Vendor Management System (VMS) and other technology enhancements[13] Financial Performance and Outlook - In Q3 2024, Cross Country Healthcare reported revenue of $315.1 million, a gross margin of 20.4%, adjusted EBITDA of $10.3 million, and adjusted EPS of $0.12[70] - Q4 2024 guidance includes revenue between $300 million and $310 million, adjusted EBITDA between $11 million and $13 million, and adjusted EPS between $0.10 and $0.14[72] - The company has a strong liquidity profile with $64 million in cash and cash equivalents and zero net funded debt[76] Market Dynamics and Trends - Healthcare jobs represented 26% of all job growth over the last twelve months[59] - September 2024 employment increased approximately 4% compared to the prior year[59] - Aging demographics are driving increased demand for healthcare professionals, with the 65-and-older population projected to grow by 36% as of 2020[51, 52] ESG Initiatives - In 2023, the company recycled 13,603 lbs of electronic waste[28] - The company supported a community initiative to plant over 100,000 trees in the Northwest region of the US in 2022[32] - In 2023, Cross Country Healthcare raised and donated approximately $300,000 to nearly 30 non-profit partner organizations[37]